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PEMBINAAN VEKTOR PEMINDAHAN BACULOVIRUS UNTUK 
PENGEKSPRESAN ISOFORM KOLINA DAN ETANOLAMINA 
KINASE MANUSIA DALAM SEL SERANGGA 
ABSTRAK 
Fosfatidikolina dan fosfatidietanolamina merupakan fosfolipid yang paling banyak 
terdapat di dalam sel eukariot. Kolina kinase dan etanolamina kinase manusia 
memainkan peranan yang amat penting dalam biosintesis fosfatidikolina dan 
fosfatidietanolamina dengan merangsangkan fosforilasi pertama dalam rangkaian 
tersebut. Dalam kajian ini, fragmen gen isoform kolina kinase-~ dan etanolamina 
kinase-2~ manusia dimasukkan ke dalam plasmid yang baru dibina. Plasmid ini dibina 
daripada plasmid pemindahan pBAC4x-1 yang dibeli. Rangka bacaan terbuka kolina 
kinase-~ dan etanolamina kinase-2~ manusia dimasukkan selepas promoter polihedrin 
untuk dihasilkan sebagai protein yang berlabel histidin. Pembinaan tersebut sedia untuk 
rekombinasi homologus dengan genom Virus Autographa ca/ifornica Nuclear 
Polyhedrosis. Sel serangga yang dijangkiti oleh Virus Autographa ca/ifornica Nuclear 
Polyhedrosis rekombinan dijangka akan menghasilkan protein kolin kinase-~ dan 
etanolamin k.inase-2~ manusia. 
.. 
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CONSTRUCTION OF BACULOVIRUS TRANSFER VECTORS 
FOR INSECT CELL EXPRESSION OF HUMAN CHOLINE AND 
ETHANOLAMINE KINASE ISOFORMS 
ABSTRACT 
Phosphatidylcholine and phosphatidylethanolamine are the most abundant phospholipid 
in eukaryotic cell membrane. Hwnan choline kinase and ethanolamine kinase play a 
very important role in the biosynthesis of phosphatidylcholine and 
phosphatidylethanolamine by catalyzing in the first phosphorylation step of the pathway. 
In this study, genes encoding hwnan choline kinase-P (hCK-P) and ethanolamine 
kinase-2P (hEK-2P) isoform gene fragments were inserted into newly constructed 
plasmid. The plasmid was constructed from commercially purchased transfer plasmid 
pBAC4x-1. Open reading frames (ORF) ofhCK-P and hEK-2P were introduced into the 
downstream of polyhedrin promoter for expression as histidine-tagged (his-tag) proteins. 
The constructs were ready for homologous recombination with Autographa californica 
Nuclear Polyhedrosis Virus (AcNPV) genome. Insect cells infected with the 




Formerly known as lecithin, phosphatidylcholine (PtdCho) was firstly discovered by 
Gobley in 1847 which presented as a component in egg yolk (Vance and Vance, 2008). 
It is the major component of phospholipid in eukaryote, constituting for about 50% of 
phospholipid in the cells and more than half of serum phospholipids (Kent, 1990). 
PtdCho plays a major structural role in cell membrane structure by forming the bilayer 
matrix (Kent, 1990), particularly at the outer leaflet of plasma membrane. 
In mammalian respiratory system, PtdCho (in dipalmitoyl-PtdCho form) interacts with 
surfactant-associated protein B to form pulmonary surfactant. Pulmonary surfactant is 
important in lowering alveoli surface tension at the pulmonary air and water interface, 
thus preventing alveolar collapse (van Golde1988). The importance of PtdCho in 
forming pulmonary surfactant is no doubt because study showed that the secretion of 
PtdCho was inhibited when surfactant was added in alveolar type II cells, suggesting the 
surfactant synthesis and secretion was under feedback inhibitory control (Dobbs et al., 
1987). 
PtdCho acts as the substrate for lecithin:cholesterol acyltransferase (LCA T). It is 
important as a regulator for the activity of LCAT (Parks et al., 2000). LCAT transfers 
the fatty acyl group of PC to cholesterol, forming cholesterol ester (Aron et al., 1978) 
which can then be transported from peripheral tissues to liver for excretion through 
reverse cholesterol transport. LCAT is also predominant in HDL maturation and 
distribution in the body. 
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Moreover, PtdCho is the major component of human plasma lipoprotein. Together with 
other phospholipids, they form outer coat of mature lipoprotein particles surrounding 
the core of non-polar lipids for lipid transport. 
Exton (1990) reported that the breakdown product of PtdCho caused cell signaling, 
rendering it to be secondary cell signal messenger (Figure 1.1 ). PtdCho can be 
hydrolyzed by Phospholipase A2, C and D. Arachidonic acid, diacylglycerol (DAG) 
LysoPtdCho and phosphatidic acid are among the signaling molecules generated from 
PtdCho (Cui and Houweling, 2002), which serve some physiological functions. 
1.2 Phospbatidyletbanolamine 
Phosphatidylethanolamine (PtdEtn), formerly known as cephatin, appears to be the most 
abundant phospholipid in mammalian cell membrane after PtdCho, where it consists of 
about 20 to 50% of total phospholipids. However, the distribution of PtdEtn in 
mammalian is distinct. As much as 45% phospholipids of the brain are consisted of 
PtdEtn. The level of PtdEtn is relatively low in hepatocytes where it constitutes only 
about 20% of total phospholipid. (Vance, 2008) 
It should be noted that the distribution and composition of PtdEtn is not only happened 
in different mammalian cells. For each cell, the distribution of PtdEtn in between inner 
leaftlet and outer leaflet of cell membrane is asymmetrical. It was reported that more 
than 80% of PtdEtn were located within the inner leaflet of cell membrane. This is in 
contrast with PtdCho where the majority of PtdCho is located at the outer leaftlet of cell 
membrane. This asymmetric distribution is maintained partly by aminophospholipid 
translocase that catalyzes PtdEtn to be transferred from outer leaflet into inner leaflet of 
2 
Cascades leading to the activation of phospholipase 
PLD 
DAG _____ _ PA---







































Figure 1.1: Signaling mediators generated from PtdCho upon cell stimulation. 
Abbreviations are as follows: AA, arachidonic acid; DAG, diacylglycerol; DAGK, 
diacylglycerol kinase; LP A, lysophosphatidic acid; P A, phosphatidic acid; P APase, 
phosphatidic acid phosphohydrolase; PtdCho, phosphatidylcholine; PtdCho-PLC, 
phosphatidylcholinespecific phospholipase C; PKC, protein kinase C; PLA2, 
phospholipase A2; PLD, phospholipase D (Cui and Houweling, 2002). 
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cell membrane. In intracellular, the PtdEtn content of mitochondrion, especially in its 
inner membrane, is particularly higher than the other cell organelles (Vance, 2008). 
PtdEtn may involve in lipoprotein secretion in the liver. It was reported that nascent 
hepatic very low density lipoprotein (VLDL) was enriched with PtdEtn in the Golgi 
fraction of mice hepatocytes upon treated with lipase inhibitor. However, this VLDL 
with PtdEtn enrichment was not being demonstrated to be transferred into plasma, 
indicated by lower total phospholipid content of VLDL secreted from hepatocytes. This 
nascent VLDL might undergo secretory pathways before being secreted into plasma. 
(Agren et al., 2005) 
Besides that, it has been observed that sarcolemmal disruption and irreversible cell 
damage occurred during ischemic heart disease because the distribution of PtdEtn in 
sarcolemmal membranes was altered, indicating the important role of PtdEtn 
metabolism in heart. (Post eta/., 1995) 
Emoto et a/. (1997) reported that during early cell apoptosis, PtdEtn as well as 
phosphatidylserine (PS) were exposed on the cell surface. This led to the loss of 
asymmetric bilayer distribution of aminophospholidpid of cell membrane bilayer, which 
caused the apoptotic cells to be recognized and eventually engulfed by phagocytes. 
PtdEtn also involves in cell surface signaling. The ethanolamine moiety is donated by 
PtdEtn for glycosylphosphatidylinositol to anchor cell surface signaling proteins to the 
lipid bilayer of plasma membrane (Menon and Stevens, 1992). 
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1.3 Biosynthesis of Phospbatidylcboline 
PtdCho biosynthesis is achieved through three distinct pathways. COP-choline pathway, 
which is also known as Kennedy pathway in the honor of Kennedy and co-worker to 
describe the pathway (Kennedy and Weiss, 1956) is the main pathway of PtdCho 
biosynthesis. Choline served as the precursor for the pathway. In animal cells, most of 
the choline is not made de novo. As the first precursor in COP-choline pathway, animal 
cell choline is supplied mainly through diet, even though choline deficiency is unlikely 
to occur. For COP-choline pathway to be initiated, choline is needed to be transported, 
mainly by facilitated diffusion from extracellular matrix into the cells. This is achieved 
by two mechanisms, which are high affinity Na +-dependent transporter and low affinity 
Na+-independent transporter (Haeffner, 1975). Upon being transported from 
extracellular into cytosol, choline will be phosphorylated by choline kinase (CK) in the 
presence of adenosine triphosphate (ATP) to produce phosphocholine (PChol). Then, 
cytidine monophosphate (CMP) is transferred from cytidine triphosphate (CTP) to 
PChol to form cytidine diphosphate-choline (COP-choline). This step is catalyzed by 
CTP:phosphocholine cytidylyltransferase (CCT), which is also the key step described 
by Kennedy and Weiss (1956) leading to the completion of COP-choline pathway. This 
activated headgroup is condensed with diacylglycerol by COP-choline:l,2-
diacylglycerol cholinephosphotransferase (CPT) in endoplasmic reticulum (ER) to 
produce the fmal product of the pathway- PtdCho. 
COP-choline pathway has been studied well by researchers. Each and every step in the 
pathway has been well studied and reported as a regulatory key enzyme for the pathway. 
However, in most of metabolic pathways, the regulation is determined by many 
enzymes in a variety of conditions. Haeffner (1975) reported that extracellular choline 
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uptake by the cells was found to be a rate-limiting step. This was due to the fact that the 
rate of choline phosphorylation was determined by the extracellular choline 
concentration. However, estrogen stimulation on young rooster caused an increase in 
PChol which was due to increased activity of choline kinase and resulted a doubling rate 
of PtdCho biosynthesis (Vigo and Vance, 1981). In murine 3T3 cells, choline kinase 
activity in the cells and cell-free extract were shown to increase by 2-fold after 
introducing mitogenic growth factors (Warden and Friedkin, 1984). When C3H10Tl/2 
cells were transfected with Harvey-ras oncogene, CK activity was observed to increase 
2-fold but CCT activity was reduced to 50%, where the authors proposed this down 
regulation may be related to fine tuning ofPtdCho biosynthesis (Teegarden et al., 1990). 
CCT was firstly shown to be a rate limiting enzyme of COP-choline pathway by Vance 
et a/. (1980). They reported an increase of CPT levels in HeLa cells transfected by 
poliovirus. The turnover rate of CCT was also being enhanced more than 2-fold by 
poliovirus, which led to a conclusion that poliovirus stimulated the rate of CCT reaction, 
causing the rate of PtdCho synthesis to increase. Another research group performed 
study of PtdCho biosynthesis regulation on embryonic chick muscle cells treated with 
phospholipase C. Activities of CK, CPT and some other enzymes were observed to be 
similar with control cells, except for CCT where its activity increased 3-fold. Supported 
by the level of PChol decreased and the level of COP-choline increased, they identified 
that CCT was the regulatory enzyme for choline flux in the cells (Sleight and Kent, 
1980). In conjunction with previous study, Wright et a/. (1985) proposed the CCT 
translocation hypothesis after the group showed that CCT activity increased when it 
reversibly associated with cellular membrane upon phospholipase C treatment. The 
active form of CCT was membrane-bound while free form of CCT was located in the 
cytosol. The reversible association of CCT with cellular membranes was involved in 
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regulating PtdCho biosynthesis. The sole study by Bjornstad and Bremer (1966) showed 
that CCT was at equilibrium in vivo, so it was unlikely to be involved in the regulatory. 
The second PtdCho biosynthesis pathway involves the conversion of PtdEtn to PtdCho 
by PtdEtn methylation (Bremer and Greenberg, 1959). This pathway is mainly involved 
in mammalian liver and relatively quantitative insignificance in other cells. It is 
achieved in three successive methylation by a single enzyme phosphatidylethanolamine 
N-methyltransferase (PEMT), with S-adenosylmethionine (SAM) as the source of 
methyl group to produce PtdCho. 
Another pathway which is currently only discovered to be working in bacteria involves 
the reaction of choline with COP-OAG to form PtdCho and CMP (Sohlenkamp et a/., 
2003). 
The pathways of PtdCho biosynthesis are shown in Figure 1.2. 
1.4 Biosynthesis of Phosphatidylethanolamine 
In eukaryotic cells, there are four major pathways which led to PtdEtn biosynthesis 
(Figure 1.3). The first and foremost pathway is named as COP-ethanolamine pathway. 
The COP-ethanolamine pathway, also known as Kennedy pathway, was elucidated by 
Kennedy and Weiss in 1956. COP-ethanolamine pathway uses ethanolamine as the 
precursor for PtdEtn synthesis. Ethanolamine is mostly obtained from diet, while PtdEtn 
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Figure 1.2: Pathways of PtdCho biosynthesis (Kent, 1990). A TP, adenosine triphosphate; 
CCT, CTP:phosphocholine cytidylyltransferase; CPT, COP-choline: 1 ,2-diacylglycerol 
cholinephosphotransferase; CTP, cytidine triphosphate; SAM, S-adenosylmethionine. 
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Figure 1.3: Biosynthesis ofPtdEtn. The numbers indicate the enzymes. 1, ethanolamine 
kinase; 2, CTP:phosphoethanolamine cytidylyltransferase; 3, COP-ethanolamine: 1,2-
diacylglycerol ethanolaminephosphotransferase; 4, phosphotidylserine synthase-2; 5, 
phosphotidylserine decarboxylase; 6, acyl-CoA:lyso-phosphatidylethanolamine 
acyltransferase (Vance and Vance, 2008). 
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In the pathway, the first reaction involves the phosphorylation of ethanolamine by 
ethanolamine kinase (EK), producing phosphoethanolamine (PEtn). After that, PEtn is 
converted by cytosolic CTP:phosphoethanolamine cytidylyltransferase (ECT) to form 
COP-ethanolamine. Lastly, with the catalysis of COP-ethanolamine:1,2-diacylglycerol 
ethanolaminephosphotransferase (EPT) which is located mainly in ER and nuclear 
envelope membrane, PEtn moiety of COP-ethanolamine is transferred to OAG to 
synthesize the fmal product of the pathway, PtdEtn. 
The regulation of COP-ethanolamine pathway is controversial. It has been reported that 
ECT was a rate limiting enzyme in the pathway (Bladergroen and van Golde, 1997). 
However, McMaster and Choy (1992) reported the accumulation of radiolabelled 
ethanolamine occurred in the Hamster heart, indicating that the phosphorylation of 
ethanolamine by EK was the rate limiting step. Besides that, OAG was showed to be a 
regulator COP-ethanolamine pathway in the condition of high glucagon level which 
caused OAG supply to decrease (Tijburg et al., 1989b ). 
The other three PtdEtn biosynthesis pathways involve the modification of pre-existing 
phospholipid. PS decarboxylation pathway is the second major PtdEtn biosynthesis 
pathway after COP-ethanolamine pathway (Kanfer and Kennedy, 1964). The enzyme 
that involves in this pathway is PS decarboxylase which is located at the outer leaflet of 
mitochondrion inner membrane (Zborowski et al., 1983). The origin of PS synthesis is 
in ER. So in order to initiate this pathway, PSis needed to be transported from ER into 
mitochondrial inner membrane, where PS is decarboxylated into PE upon reacted with 
PS decarboxylase. 
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Other PtdEtn synthesis pathways are acylation of lyso-PtdEtn and base-change reaction 
between ethanolamine and serine of PS, where the quantity is minor and insignificant. 
In comparing with COP-ethanolamine pathway where PtdEtn synthesis occurs at ER, 
PS decarboxylation pathway is limited in mitochondrion, suggesting two different 
PtdEtn biosynthesis pathways in the cells \'1 ance and Vance, 2008). Most of PtdEtn 
synthesized from PS decarboxylation pathway retain in the mitocondria, so it is possible 
that PS decarboxylation pathway is potentially important for mitocondria (Bleijerveld et 
a/., 2007). 
PtdEtn biosynthesis pathway depends on the cell type. Zalinski and Choy (1982) studied 
the PtdEtn biosynthesis pathway of isolated hamster heart using radiolabeled 
ethanolamine perfusion. They found out that COP-ethanolamine pathway was the main 
pathway of PtdEtn biosynthesis in hamster heart while PS decarboxylation and base-
change reaction lead to minor contribution of PtdEtn synthesis. Study on rat isolated 
hepatocytes also revealed that COP-ethanolamine pathway was the main PtdEtn 
biosynthesis pathway for rat hepatocytes compared with PS decarboxylation pathway 
(Tijburg eta/., 1989a). However, PS decarboxylation pathway was important for PtdEtn 
biosynthesis in many types of cells even though ethanolamine was abundant \Voelker, 
1984). 
The species of PtdEtn synthesized by COP-ethanolamine pathway and PS 
decarboxylation pathway are different. Although both pathways produce diacyl-PtdEtn 
species, most of the species are prone to be synthesized by one pathway. It was reported 
that PtdEtn with mono or diunsaturated fatty acids at sn-2 position was preferentially 
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